The DOI matches its Crossref record; 260 of the 264 references it cites were found in a registry or an index.
Neurobiology of the nicotine withdrawal syndrome
Abstract
The aversive aspects of withdrawal from chronic nicotine exposure are thought to be an important motivational factor contributing to the maintenance of the tobacco habit in human smokers. Much emphasis has been placed on delineating the underlying neurobiological mechanisms mediating different components of the nicotine withdrawal syndrome. Recent studies have shown that both central and peripheral populations of nicotinic acetylcholine receptors (nAChRs) are involved in mediating somatic signs of nicotine withdrawal as measured by the rodent nicotine abstinence scale. However, only central populations of nAChRs are involved in mediating affective aspects of nicotine withdrawal, as measured by elevations in brain-stimulation reward thresholds and conditioned place aversion. Nicotine interacts with several neurotransmitter systems, including acetylcholine, dopamine, opioid peptides, serotonin, and glutamate systems. Evidence so far suggests that these neurotransmitters play a role in nicotine dependence and withdrawal processes. The available evidence also suggests that different underlying neurochemical deficits mediate somatic and affective components of nicotine withdrawal. The aim of the present review is to discuss preclinical findings concerning the neuroanatomical and neurochemical substrates involved in these different aspects of nicotine withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dependence on tobacco smoking depends not only on the balance between the rewarding and aversive action of nicotine described above, but also on escape from the aversive consequences of nicotine withdrawal (Doherty et al. 1995;Kenny and Markou 2001).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“The most common somatic symptoms include bradycardia, gastrointestinal discomfort, and increased appetite.”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“Affective symptoms primarily include depressed mood including anhedonia, dysphoria, anxiety, irritability, difficulty concentrating, and craving (Parrott 1993;Doherty et al. 1995;Kenny and Markou 2001).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“The nicotine withdrawal syndrome in abstinent smokers is comprised of”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kenny and Markou 2001
In the citing paper
“The neuroadaptations arising from chronic nicotine exposure cause widespread alterations in brain neurotransmission that promote and sustain the use of tobacco [21–24].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [22]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
NEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N. R., Feighner, J. P., Shrivastava, R. K., Carman, J. S., Sramek, J. J., Reines, S. A., Liu, G. F., Snavely, D. B., Wyatt-Knowles, E. S., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Research works printed but not linked: 3
- Paterson, 2001, Nicotine self-administration in rats: short-term abstinence, progressive ratio schedule, and extinction with or without conditioned stimuli, Drug Alcohol Depend, 63, S120
- Ridley, 1997, The influence of nicotine on 5-HT overflow in the dorsal hippocampus of the rat, Br J Pharmacol, 112, 301P
- Wonnacott, 1993, Methyllycaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses, Methods Neurosci, 12, 263
Cited by
Sorted by citations
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
The dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Cue dependency of nicotine self-administration and smoking
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A., & Sved, A. F. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00676-1 · Cited by 425
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“In the conditioned place-aversion paradigm, the animal learns to avoid the compartment in which nicotine withdrawal is experienced (Jackson et al. 2009, Kenny & Markou 2001).”
BackgroundWhat Keeps Us Awake: the Neuropharmacology of Stimulants and Wakefulness Promoting Medications
Boutrel, B., & Koob, G. F. (2004) · SLEEP · doi:10.1093/sleep/27.6.1181 · Cited by 310
Neurobiology of nicotine dependence
Markou, A. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0095 · Cited by 274
Self-citationPerioperative Abstinence from Cigarettes
Warner, D. O., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200602000-00023 · Cited by 258
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223
Self-citationJackson, K. J., Martin, B. R., Changeux, J. P., & Damaj, M. I. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132977 · Cited by 208
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207
Jhou, T. C., Good, C. H., Rowley, C. S., Xu, S., Wang, H., Burnham, N. W., Hoffman, A. F., Lupica, C. R., & Ikemoto, S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3634-12.2013 · Cited by 211
Effects of Nicotine in Experimental Animals and Humans: An Update on Addictive Properties
Foll, B. L., & Goldberg, S. R. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_12 · Cited by 200
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Dulawa, S. C., & Janowsky, D. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0219-x · Cited by 187
Defining nicotine dependence for genetic research: evidence from Australian twins
LESSOV, C. N., MARTIN, N. G., STATHAM, D. J., TODOROV, A. A., SLUTSKE, W. S., BUCHOLZ, K. K., HEATH, A. C., & MADDEN, P. A. F. (2004) · Psychological Medicine · doi:10.1017/s0033291703001582 · Cited by 185
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 186
Self-citationMcLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 191
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript avoiding environments paired with withdrawal serves as an indicator of the severity of aversion (Kenny and Markou 2001).”
BackgroundHughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701188927 · Cited by 173
A C. elegans Model of Nicotine-Dependent Behavior: Regulation by TRP-Family Channels
Feng, Z., Li, W., Ward, A., Piggott, B. J., Larkspur, E. R., Sternberg, P. W., & Xu, X. Z. S. (2006) · Cell · doi:10.1016/j.cell.2006.09.035 · Cited by 173
Zhao-Shea, R., DeGroot, S. R., Liu, L., Vallaster, M., Pang, X.-Y., Su, Q., Gao, G., Rando, O. J., Martin, G. E., George, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms7770 · Cited by 169
Stress is a principal factor that promotes tobacco use in females
Torres, O. V., & O'Dell, L. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.04.005 · Cited by 164
Nicotine exposure during adolescence induces a depression-like state in adulthood
Iñiguez, S. D., Warren, B. L., Parise, E. M., Alcantara, L. F., Schuh, B., Maffeo, M. L., Manojlovic, Z., & Bolaños-Guzmán, C. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.220 · Cited by 157
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Self-citationSmoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers
Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.1.3 · Cited by 154
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154
Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction
O’Dell, L. E., Bruijnzeel, A. W., Smith, R. T., Parsons, L. H., Merves, M. L., Goldberger, B. A., Richardson, H. N., Koob, G. F., & Markou, A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0383-6 · Cited by 153
Self-citationMeasuring the emergence of tobacco dependence: the contribution of negative reinforcement models
Eissenberg, T. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00735.x · Cited by 159
Dopamine and addiction: what have we learned from 40 years of research
Solinas, M., Belujon, P., Fernagut, P., Jaber, M., & Thiriet, N. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1957-2 · Cited by 163
Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice
Davis, J. A., James, J. R., Siegel, S. J., & Gould, T. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2853-05.2005 · Cited by 146
D’Souza, M. S., & Markou, A. (2011) · Europe PMC (PubMed Central) · Cited by 138
Self-citationKenny, P. J., Gasparini, F., & Markou, A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052027 · Cited by 138
Self-citationFowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131
Self-citationTuesta, L. M., Fowler, C. D., & Kenny, P. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.026 · Cited by 134
Self-citationZhao-Shea, R., Liu, L., Pang, X., Gardner, P. D., & Tapper, A. R. (2013) · Current Biology · doi:10.1016/j.cub.2013.09.041 · Cited by 129
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 132
Self-citationCurrent and emerging pharmacotherapies for treating tobacco dependence
Schnoll, R. A., & Lerman, C. E. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.429 · Cited by 117
Schindler, A. G., Messinger, D. I., Smith, J. S., Shankar, H., Gustin, R. M., Schattauer, S. S., Lemos, J. C., Chavkin, N. W., Hagan, C. E., Neumaier, J. F., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3220-12.2012 · Cited by 122
Power Spectral Analysis of EEG Activity During Sleep in Cigarette Smokers
Zhang, L., Samet, J., Caffo, B. S., Bankman, I. N., & Punjabi, N. M. (2007) · CHEST Journal · doi:10.1378/chest.07-1190 · Cited by 117
Balerio, G. N., Aso, E., Berrendero, F., Murtra, P., & Maldonado, R. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03714.x · Cited by 116
Rahman, S., Zhang, J., Engleman, E. A., & Corrigall, W. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.010 · Cited by 110
Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems
Kenny, P. J., & Markou, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4785-04.2005 · Cited by 107
Self-citationNeural Substrates of Psychostimulant Withdrawal-Induced Anhedonia
D’Souza, M. S., & Markou, A. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_20 · Cited by 108
Self-citationSmoking Behaviour and Mental Health Disorders—Mutual Influences and Implications for Therapy
Minichino, A., Bersani, F. S., Calò, W. K., Spagnoli, F., Francesconi, M., Vicinanza, R., Chiaie, R. D., & Biondi, M. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10104790 · Cited by 110
Improgo, M. R., Scofield, M. D., Tapper, A. R., & Gardner, P. D. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.05.003 · Cited by 108
Nortriptyline for smoking cessation: A review
Hughes, J. R., Stead, L. F., & Lancaster, T. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500185298 · Cited by 103
An essential role of acetylcholine-glutamate synergy at habenular synapses in nicotine dependence
Frahm, S., Antolin-Fontes, B., Görlich, A., Zander, J.-F., Ahnert-Hilger, G., & Ibañez-Tallon, I. (2015) · eLife · doi:10.7554/elife.11396 · Cited by 98
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99
Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers
Epstein, L. H., Wright, S. M., Paluch, R. A., Leddy, J. J., Hawk, L. W., Jaroni, J. L., Saad, F. G., Crystal-Mansour, S., Shields, P. G., & Lerman, C. E. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.82 · Cited by 98
David, S. P., Munafo, M. R., Johansen‐Berg, H., MacKillop, J. M., Sweet, L. H., Cohen, R. A., NIAURA, R. S., Rogers, R. D., Matthews, P. M., & Walton, R. T. (2007) · Brain Imaging and Behavior · doi:10.1007/s11682-007-9004-1 · Cited by 98
Neuropharmacology and potential efficacy of new treatments for tobacco dependence
Fagerström, K. O., & Balfour, D. J. K. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.2.107 · Cited by 95
Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95
Positive reactions to tobacco predict relapse after cessation.
Strong, D. R., Leventhal, A. M., Evatt, D. P., Haber, S. N., Greenberg, B. D., Abrams, D. B., & NIAURA, R. S. (2011) · Journal of Abnormal Psychology · doi:10.1037/a0023666 · Cited by 94
Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1414-1 · Cited by 93
Self-citationDifferent physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice
Ponzoni, L., Moretti, M., Sala, M., Fasoli, F., Mucchietto, V, Lucini, V, Cannazza, G., Gallesi, G., Castellana, C., Clementi, F., et al. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.010 · Cited by 91
In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco
Sharma, A., & Brody, A. L. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_6 · Cited by 90
Treatment of stable chronic obstructive pulmonary disease
Rennard, S. I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16941-9 · Cited by 93
Nicotinic acetylcholine receptors in neurological and psychiatric diseases
Terry, A. V., Jones, K., & Bertrand, D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106764 · Cited by 90
Johnson, P. M., Hollander, J. A., & Kenny, P. J. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.024 · Cited by 90
Self-citationIncreased anxiety-like behavior in adult rats exposed to nicotine as adolescents
Slawecki, C. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00093-5 · Cited by 87
Deficits in a sustained attention task following nicotine withdrawal in rats
Shoaib, M., & Bizarro, L. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2004-6 · Cited by 87
Pogocki, D., Ruman, T., Danilczuk, M., Danilczuk, M., Celuch, M., & Wałajtys-Rode, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.038 · Cited by 84
Animal models and treatments for addiction and depression co-morbidity
Paterson, N. E., & Markou, A. (2007) · Neurotoxicity Research · doi:10.1007/bf03033479 · Cited by 85
Self-citationPang, X.-Y., Liu, L., Ngolab, J., Zhao-Shea, R., McIntosh, J. M., Gardner, P. D., & Tapper, A. R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.039 · Cited by 89
A psychobiological framework of the substrates that mediate nicotine use during adolescence
O'Dell, L. E. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.039 · Cited by 81
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
Cippitelli, A., Astarita, G., Duranti, A., Caprioli, G., Ubaldi, M., Stopponi, S., Kallupi, M., Sagratini, G., de Fonseca, F. R., Piomelli, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028142 · Cited by 81
Nicotinic acetylcholine receptors: an overview on drug discovery
D’hoedt, D., & Bertrand, D. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902841045 · Cited by 79
Skosnik, P. D., Edwards, C. R., O’Donnell, B. F., Steffen, A., Steinmetz, J. E., & Hetrick, W. P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301506 · Cited by 78
Fowler, C. D., Tuesta, L. M., & Kenny, P. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3235-1 · Cited by 79
Self-citationNicotine behavioral pharmacology: Clues from planarians
Rawls, S. M., Patil, T., Tallarida, C. S., Baron, S. H., Kim, M., Song, K., Ward, S. J., & Raffa, R. B. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.04.001 · Cited by 80
Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion
Cryan, J. F., Gasparini, F., Heeke, G. V., & Markou, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02890-3 · Cited by 77
Self-citationA mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females
O’Dell, L. E., & Torres, O. V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.055 · Cited by 78
Besson, M., David, V., Suarez, S., Cormier, A., Cazala, P., Changeux, J.-P., & Granon, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0418-z · Cited by 73
Hopkins, T. J., Rupprecht, L. E., Hayes, M. R., Blendy, J. A., & Schmidt, H. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.83 · Cited by 73
Changes in food reward following smoking cessation: a pharmacogenetic investigation
Lerman, C. E., Berrettini, W. H., Pinto, A. G., Patterson, F., Crystal-Mansour, S., Wileyto, E. P., Restine, S., Leonard, D. G. B., Shields, P., & Epstein, L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1823-9 · Cited by 71
Lotfipour, S., Byun, J. S., Leach, P., Fowler, C. D., Murphy, N. P., Kenny, P. J., Gould, T. J., & Boulter, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4731-12.2013 · Cited by 68
Self-citationFletcher, P. J., Rizos, Z., Noble, K., Soko, A. D., Silenieks, L. B., Lê, A. D., & Higgins, G. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.023 · Cited by 70
Yeom, M., Shim, I., Lee, H., & Hahm, D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.034 · Cited by 72
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal
Zaniewska, M., McCreary, A. C., Wydra, K., & Filip, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.006 · Cited by 68
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66
Li, W., Jiang, K., Yuan, W., Cui, W., & Li, M. D. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8997-x · Cited by 68
Rodent models for nicotine withdrawal
Chellian, R., Behnood‐Rod, A., Bruijnzeel, D. M., Wilson, R., Pandy, V., & Bruijnzeel, A. W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211005629 · Cited by 71
From smoking to lung cancer: the CHRNA5/A3/B4 connection
Improgo, M. R., Scofield, M. D., Tapper, A. R., & Gardner, P. D. (2010) · Oncogene · doi:10.1038/onc.2010.256 · Cited by 67
Bupropion for the treatment of nicotine withdrawal and craving
Mooney, M. E., & Sofuoglu, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.965 · Cited by 65
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Self-citationHistorical and current perspective on tobacco use and nicotine addiction
Dani, J. A., & Balfour, D. J. K. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.001 · Cited by 67
Levis, S. C., Baram, T. Z., & Mahler, S. V. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15223 · Cited by 63
Laviolette, S. R., Lauzon, N. M., Bishop, S. F., Sun, N., & Tan, H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1371-08.2008 · Cited by 59
Atomoxetine Reverses Nicotine Withdrawal-Associated Deficits in Contextual Fear Conditioning
Davis, J. A., & Gould, T. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301315 · Cited by 52
Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum
Isola, R., Zhang, H., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1315-4 · Cited by 52
Mannucci, C., Tedesco, M., Bellomo, M., Caputi, A. P., & Calapai, G. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.010 · Cited by 51
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence
Herman, R. J., & Schmidt, H. D. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114565 · Cited by 54
Vlachou, S., & Markou, A. (2010) · Neuromethods · doi:10.1007/978-1-60761-934-5_1 · Cited by 51
Self-citationAssociative Learning, the Hippocampus, and Nicotine Addiction
Gould, T. J., & Davis, J. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801010009 · Cited by 49
DiFranza, J. R., Ursprung, W. W. S., Lauzon, B., Bancej, C. M., Wellman, R. J., Ziedonis, D. M., Kim, S. S., Gervais, A., Meltzer, B., McKay, C. E., et al. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.12.013 · Cited by 49
The Natural History and Diagnosis of Nicotine Addiction
DiFranza, J. R., Wellman, R. J., Mermelstein, R. J., Pbert, L. A., Klein, J. D., Sargent, J. D., Ahluwalia, J. S., Lando, H. A., Ossip, D. J., Wilson, K. M., et al. (2011) · Current Pediatric Reviews · doi:10.2174/157339611795735648 · Cited by 49
Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement
López‐Moreno, J. A., Trigo-Díaz, J. M., de Fonseca, F. R., González‐Cuevas, G., de Heras, R. G., Crespo, I., & Navarro, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.002 · Cited by 49
Motaghinejad, M., Fatima, S., Karimian, M., & Ganji, S. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2014-0128 · Cited by 48
Associations between Cloninger's temperament dimensions and acute tobacco withdrawal
Leventhal, A. M., Waters, A. J., Boyd, S. J., Moolchan, E. T., Heishman, S. J., Lerman, C. E., & Pickworth, W. B. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.06.014 · Cited by 46
Effects of oxytocin on nicotine withdrawal in rats
Manbeck, K. E., Shelley, D., Schmidt, C. E., & Harris, A. C. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.002 · Cited by 44
Grieder, T. E., Sellings, L. H. L., Vargas-Pérez, H., Ting‐A‐Kee, R. A., Siu, E. C. K., Tyndale, R. F., & van der Kooy, D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.198 · Cited by 45
Nicotine induces morphological and functional changes in astrocytes via nicotinic receptor activity
Aryal, S. P., Fu, X., Sandin, J. N., Neupane, K. R., Lakes, J. E., Grady, M. E., & Richards, C. I. (2021) · Glia · doi:10.1002/glia.24011 · Cited by 48
Metadata
- Authors
- Kenny, P. J., & Markou, A.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Markou, Athina
- ORCID
- Kenny, Paul J.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 70
- Issue
- 4
- Pages
- 531-549
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2020567468
- Cited by
- 310
- References
- 264
- Citations by year
- 2025: 9 · 2024: 7 · 2023: 10 · 2022: 7 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 17 · 2014: 12 · 2013: 19 · 2012: 18
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 11946, R56DA011946)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine withdrawal, nicotine dependence, nicotinic acetylcholine receptors, somatic withdrawal signs, conditioned place aversion, dopamine, opioid peptides, serotonin, glutamate, acetylcholine, neuroanatomical substrates
- MeSH terms
- Animals, Humans, Nicotine, Substance Withdrawal Syndrome, Nicotinic Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review